# EDGAR Filing Document

**Accession Number:** 0001678848
**File Stem:** 0001213900-23-005512
**Filing Date:** 2023-1
**Character Count:** 45170
**Document Hash:** b88cee24ce5cfd544af0479d698fb3dc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-005512.hdr.sgml**: 20230127

**ACCESSION NUMBER**: 0001213900-23-005512

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 35

**CONFORMED PERIOD OF REPORT**: 20220930

**FILED AS OF DATE**: 20230127

**DATE AS OF CHANGE**: 20230127

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BITMIS CORP.
- **CENTRAL INDEX KEY:** 0001678848
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 981310024
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-214469
- **FILM NUMBER:** 23560126

**BUSINESS ADDRESS:**
- **STREET 1:** UNIT NO. 5784
- **STREET 2:** 152 CHARTERED SQUARE BUILDING, 212/19
- **CITY:** BANGKOK
- **STATE:** W1
- **ZIP:** 10500
- **BUSINESS PHONE:** 7026050123

**MAIL ADDRESS:**
- **STREET 1:** UNIT NO. 5784
- **STREET 2:** 152 CHARTERED SQUARE BUILDING, 212/19
- **CITY:** BANGKOK
- **STATE:** W1
- **ZIP:** 10500

?xml version="1.0" encoding="ASCII"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 10-Q**

☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**For the quarterly period ended September 30, 2022**

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ___ to ____

Commission file number 333-214469

**BITMIS CORP.**

(Exact name of registrant as specified in its charter)

**Nevada**

(State or Other Jurisdiction of Incorporation or Organization)

---

| | |
|:---|:---|
| **Nevada** | **98-1310024** |
| **(State or other jurisdiction of** | **(I.R.S. Employer** |
| **incorporation or organization)** | **Identification No.)** |

---

**400 Blake Street, Suite 3401 New Haven, Connecticut 06515**

(Address of principal executive offices, Zip Code)

(646) 768-8417

(Registrant's telephone number, including area code)

None

(Former name, former address and former fiscal year, if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," accelerated filer" "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **None** | **N/A** | **N/A** |

---

As of January 20, 2023, there were 7,250,750 common shares are issued and outstanding.

**BITMIS CORP.**

**QUARTERLY REPORT ON FORM 10-Q**

**Table of Contents**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| PART I | [FINANCIAL INFORMATION:](#a_001) | 1 |
| Item 1. | [Financial Statements (Unaudited)](#a_002) | 1 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_003) | 9 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#a_004) | 12 |
| Item 4. | [Controls and Procedures](#a_005) | 12 |
| PART II | [OTHER INFORMATION:](#a_006) | 13 |
| Item 1 | [Legal Proceedings](#a_007) | 13 |
| Item 1A | [Risk Factors](#a_008) | 13 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#a_009) | 13 |
| Item 3. | [Defaults Upon Senior Securities](#a_010) | 13 |
| Item 4. | [Mine Safety Disclosures.](#a_011) | 13 |
| Item 5. | [Other Information](#a_012) | 13 |
| Item 6. | [Exhibits](#a_013) | 13 |

---

i

**PART 1 – FINANCIAL INFORMATION**

**Item 1. Financial Statements**

The accompanying interim financial statements of Bitmis Corp. ("the Company", "we", "us" or "our") have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted principles have been condensed or omitted pursuant to such rules and regulations.

The interim financial statements are condensed and should be read in conjunction with the company's latest annual financial statements.

In the opinion of management, the financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

**BITMIS CORP.**

**CONDENSED BALANCE SHEETS**

**(In U.S. dollars)**

---

| | | |
|:---|:---|:---|
|  | September 30, <br> 2022 | June 30,<br> 2022 |
|  | (Unaudited) | |
| **ASSETS** |  |  |
| Total Assets | $**-** | $**-** |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $- | $1914 |
| &nbsp;&nbsp;&nbsp;Related party loans | - | 7358 |
| **Total Current Liabilities** | **-** | **9272** |
| **Total Liabilities** | **-** | **9272** |
| Stockholder's Deficit: |  |  |
| Preferred stock, par value $0.001, 10,000,000 shares authorized, 10,000,000 shares issued and outstanding | $10000 | $- |
| Common stock, par value $0.001; 75,000,000 shares authorized, 6,250,750 shares issued and outstanding as of March 31, 2020 and June 30, 2019 | 6251 | 6251 |
| Additional paid in capital | 56230 | 31357 |
| Accumulated deficit | (56230) | (46880) |
| Total Stockholder's Deficit | &nbsp;&nbsp;&nbsp;&nbsp;- | (9272) |
| **Total Liabilities and Stockholder's Deficit** | $**-** | **-** |

---

See accompanying notes, which are an integral part of these financial statements

**BITMIS CORP.**

**CONDENSED STATEMENTS OF OPERATIONS** 

**(Unaudited)**

**(In U.S. dollars)**

---

| | |
|:---|:---|
|  | Three months<br> ended<br> September 30, <br> 2022 |
| REVENUES | $- |
| Gross Profit |  |
| OPERATING EXPENSES |  |
| General and Administrative Expenses | 9350 |
| **TOTAL OPERATING EXPENSES** | **9350** |
| **NET LOSS FROM OPERATIONS** |  |
| PROVISION FOR INCOME TAXES | - |
| **NET LOSS** | $**9350** |
| **LOSS PER SHARE: BASIC AND DILUTED** | **(0.00)** |
| **WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED** | **6250750** |

---

See accompanying notes, which are an integral part of these financial statements

**BITMIS CORP.**

**CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)**

**(Unaudited) (In U.S. dollars)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Common Stock | Common Stock | | | |
|  | Shares | Amount | Additional <br> Paid-in<br>Capital | Accumulated<br>deficit | Total <br> Stockholder's <br> Equity<br>(Deficit) |
| **Balance, June 30, 2022** | 6250750 | 6251 | 31357 | (46880) | (9272) |
| Net loss |  |  |  | (9350) | (9350) |
| Liabilities assumed by shareholders |  |  | 18622 |  | 18622 |
| **Balance, September 30, 2022** | 6250750 | 6251 | 49979 | (56230) | - |

---

See accompanying notes, which are an integral part of these financial statements

**BITMIS CORP.**

**CONDENSED** **STATEMENT OF CASH FLOWS**

**(Unaudited)**

**(In U.S. dollars)**

---

| | |
|:---|:---|
|  | Three months <br> ended<br> September 30, <br> 2022 |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |
| Net loss for the period | $(9350) |
| Adjustments to reconcile net loss to net cash (used in) operating activities |  |
| &nbsp;&nbsp;&nbsp;Change in operating assets and liabilities |  |
| **CASH FLOWS (USED IN) OPERATING ACTIVITIES** | **(9350)** |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |
| Proceeds from related party loans | 9350 |
| **CASH FLOWS PROVIDED BY FINANCING ACTIVITIES** | **9350** |
| **NET INCRASE IN CASH** |  |
| **Cash, beginning of period** | **-** |
| **Cash, end of period** | $**-** |
| **SUPPLMENTAL CASH FLOW INFORMATION:** |  |
| &nbsp;&nbsp;&nbsp;**Interest paid** | $**-** |
| &nbsp;&nbsp;&nbsp;**Income taxes paid** | $**-** |

---

See accompanying notes, which are an integral part of these financial statements

**BITMIS CORP.**

**NOTES TO CONDENSED FINANCIAL STATEMENTS**

**Note 1 – *ORGANIZATION AND BUSINESS***

Bitmis Corp. ("the Company") was founded in the State of Nevada on June 6, 2016. The Company originally intended to commence operations in the business of consulting in Thailand but it was not successful. On February 24, 2020, Anna Varlamova, the president, treasurer, secretary and director of Bitmis Corp. sold 5,000,000 shares of the Company's common stock, representing 80% of the total issued and outstanding shares of common stock of the Company, in a private transaction (the "Transaction") to Li Wen Chen, Bi Feng Zhao, Heng Jian Yang, Kin Chiu Leung, Jin Jia Mai and Zhong Xiong Chen for an aggregate purchase price of $395,000 (the "Purchase Price"). Li Wen Chen, Bi Feng Zhao, Heng Jian Yang, Kin Chiu Leung, Jin Jia Mai and Zhong Xiong Chen (collectively, the "Purchasers") purchased, respectively, 1,250,000 shares, 1,000,000 shares, 1,000,000 shares, 750,000 shares, 500,000 shares and 500,000 shares of the common stock of the Company from Anna Varlamova. The share ownership of Li Wen Chen, Bi Feng Zhao, Heng Jian Yang, Kin Chiu Leung, Jin Jia Mai and Zhong Xiong Chen represents, respectively, 20%, 16%, 16%, 12%, 8% and 8% of the total issued and outstanding shares of common stock of the Company.

In December 2019, a novel strain of coronavirus, causing a disease referred to as COVID-19, was reported to have surfaced in Wuhan, China. Since then, COVID-19 has spread all over China and many other countries in the world. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic.

The Company's business and results of operations have been adversely affected and could continue to be adversely affected by the COVID-19 pandemic. Quarantines, travel restrictions, shelter-in-place and other restrictions related to COVID-19 have impacted the Company's abilities to visit and meet clients in China for potential merger and acquisition projects.

The global economy has also been materially negatively affected by COVID-19 and there is continued severe uncertainty about the duration and intensity of its impacts. The Chinese and global growth forecast is extremely uncertain, which could seriously affect people's investment desires in China and internationally. While the potential economic impact brought by, and the duration of, COVID-19 may be difficult to assess or predict, a widespread pandemic could result in significant disruption of global financial markets, reducing the Company's ability to access capital, which could negatively affect the Company's liquidity.

On July 8, 2020, the Board of Directors received a resignation letter from Mr. Zhong Xiong Chen, a member of the Board, effective on July 8, 2020. Mr. Chen indicated that his resignation was due to personal reasons.

On July 8, 2020, the Board received a resignation letter from Ms. Li Wen Chen, a member of the Board and Chief Financial Officer of the Company, effective on July 8, 2020. Ms. Chen indicated that her resignation was due to personal reasons.

The Company has been dormant since July, 2020.

On April 12, 2022, the Eighth Judicial District Court in Clark County, Nevada Case No: A-22-849683-B appointed Custodian Ventures, managed by David Lazar as the Company's custodian. Upon his appointment all former officers and directors of the Company resigned.

**Note 2 – *GOING CONCERN***

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements. The Company has incurred significant operating losses since its inception. As of Septembe3 30, 2022, the Company had a working capital deficit of $nil, due to liabilities assumed by the shareholder (please see note 4 for more details) and an accumulated deficit of $56,230.

The Company expects to generate operating cash flows that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company's ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its revenues support its operations.

The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all.

**NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

*<u>Basis of Presentation</u>*

The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board ("<u>FASB</u>") "FASB Accounting Standard Codification™" (the "<u>Codification</u>") which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles ("<u>GAAP</u>") in the United States.

*<u>Principles of consolidation</u>*

The consolidated financial statements include the financial statements of all the subsidiaries. All inter-company transactions and balances have been eliminated upon consolidation.

*<u>Use of estimates</u>*

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the calculation of stock-based compensation, and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation of inventory, and recoverability of carrying amount and the estimated useful lives of long-lived assets.

*<u>Cash and cash equivalents</u>*

Cash and cash equivalents consist of cash on hand, cash in bank with no restrictions, as well as highly liquid investments which are unrestricted as to withdrawal or use, and which have remaining maturities of three months or less when initially purchased. As of June 30, 2022, the Company had no cash on hand.

*<u>Income taxes</u>*

The Company accounts for income taxes under FASB ASC 740, *"Accounting for Income Taxes"*. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, *"Accounting for Uncertainty in Income Taxes"* prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position's sustainability under audit.

*<u>Net Loss per Share</u>*

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, "Earnings per Share." Basic earnings per common share ("EPS") calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

*<u>Recent Accounting Pronouncements</u>*

There are no recent accounting pronouncements that impact the Company's operations.

**NOTE 4 – RELATED PARTY NOTES PAYABLE, ACCRUED EXPENSES AND OTHER LIABILITIES**

On September 22, 2022, as a result of a private transaction 10,000,000 shares of Series A Preferred Stock, $0.001 par value per share (the "Shares") of Bitmis Corp., a Nevada corporation (the "Company"), were transferred from Custodian Ventures LLC, a Wyoming limited liability company, to Yuan Xiaoyan (the "Purchaser"). The transaction contemplated in the SPA closed on the same day (the "Closing") subject to certain post-closing delivery as set forth in the SPA. In connection with the SPA, on the same day, the Company and Custodian agreed that the liabilities would fully assumed by Custodian, as of September 22, 2022, with amount of $18,622 as part of the transaction terms.

As of September 30 and June 30, 2022, the company had nil and $1,914 in accounts payable. Besides, as of September 30 and June 30, 2022, the Company had nil and $7,358 in interest- free related party loans.

**Note 5 – *STOCKHOLDERS' EQUITY***

The Company has 75,000,000, $0.001 par value shares of common stock authorized. There were 6,250,750 shares of common stock issued and outstanding as of September 30, 2022.

Additionally, the Company's issued capital stock of Preferred Shares consists of 10,000,000 shares of Series A Preferred stock was issued to Custodian Ventures, LLC on July 20, 2022 as compensation for the funding it has provided to the Company.

**Note 6 – *COMMITMENTS AND CONTINGENCIES***

The Company did not have any contractual commitments as of September 30, 2022.

**Note 7 – *SUBSEQUENT EVENT***

 ****

On December 30, 2022, the Company entered into a share exchange agreement ("Share Exchange Agreement") with (i) Cambell International Holding Limited ("Cambell International"), a limited liability company incorporated in British Virgin Islands on September 23, 2020 and (ii) the shareholders of Cambell International (the "Cambell Shareholders") to acquire all the issued and outstanding capital stock of Cambell International in exchange for the issuance to the Cambell Shareholders of an aggregate of 1,000,000 shares (the "Shares") of the Company's common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stock owned by her ("Reverse Acquisition"). The Reverse Acquisition was closed on December 30, 2022.

**<u>ITEM 2. MANAGEMENT' DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>**

**FORWARD LOOKING STATEMENT NOTICE**

*The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q and our financial statements and notes thereto included in our annual report on Form 10-K for the fiscal year ended June 30, 2022 (the "2022 Form 10-K").* 

 

*Our Management's Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Words such as "anticipates," "expects," "intends," "plans," "predicts," "potential," "believes," "seeks," "hopes," "estimates," "should," "may," "will," "with a view to" and variations of these words or similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include international, national, and local general economic and market conditions; our ability to sustain, manage, or forecast growth; our ability to successfully make and integrate acquisitions; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; change in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; the risk of foreign currency exchange rates; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission. For more information, see our discussion of risk factors located at Part I, Item 1A of our 2019 Form 10-K.*

 

*Although the forward-looking statements in this Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.*

Financial information contained in this quarterly report and in our unaudited interim financial statements is stated in United States dollars and are prepared in accordance with United States generally accepted accounting principles.

**OVERVIEW** 

Bitmis Corp. ("the Company," "we," "us" or "our") was founded in the State of Nevada on June 6, 2016. The Company originally intended to commence operations in the business of consulting in Thailand but it was not successful. On February 24, 2020, Anna Varlamova, the president, treasurer, secretary and director of Bitmis Corp. sold 5,000,000 shares of the Company's common stock, representing 80% of the total issued and outstanding shares of common stock of the Company, in a private transaction (the "Transaction") to Li Wen Chen, Bi Feng Zhao, Heng Jian Yang, Kin Chiu Leung, Jin Jia Mai and Zhong Xiong Chen for an aggregate purchase price of $395,000 (the "Purchase Price"). Li Wen Chen, Bi Feng Zhao, Heng Jian Yang, Kin Chiu Leung, Jin Jia Mai, and Zhong Xiong Chen (collectively, the "Purchasers") purchased, respectively, 1,250,000 shares, 1,000,000 shares, 1,000,000 shares, 750,000 shares, 500,000 shares and 500,000 shares of the common stock of the Company from Anna Varlamova. The share ownership of Li Wen Chen, Bi Feng Zhao, Heng Jian Yang, Kin Chiu Leung, Jin Jia Mai and Zhong Xiong Chen represents, respectively, 20%, 16%, 16%, 12%, 8% and 8% of the total issued and outstanding shares of common stock of the Company.

In December 2019, a novel strain of coronavirus, causing a disease referred to as COVID-19, was reported to have surfaced in Wuhan, China. Since then, COVID-19 has spread all over China and many other countries in the world. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic.

The Company's business and results of operations were adversely affected and continued to be adversely affected by the COVID-19 pandemic. Quarantines, travel restrictions, shelter-in-place and other restrictions related to COVID-19 impacted the Company's abilities to visit and meet clients in China for potential merger and acquisition projects.

The global economy was also materially negatively affected by COVID-19 and there remains continued severe uncertainty about the duration and intensity of its impacts. As of the date of this Quarterly Report, the Chinese and global growth forecast is extremely uncertain, which could seriously affect people's investment desires in China and internationally. While the potential economic impact brought by COVID-19 may be difficult to assess or predict, the continued existence of COVID-19 or any of its variants could result in significant disruption of global financial markets, reducing the Company's ability to access capital and negatively affect the Company's liquidity.

**Resignations and Appointments**

On July 8, 2020, the Board of Directors received a resignation letter from Mr. Zhong Xiong Chen, a member of the Board, effective on July 8, 2020. Mr. Chen indicated that his resignation was due to personal reasons. On July 8, 2020, the Board received a resignation letter from Ms. Li Wen Chen, a member of the Board and Chief Financial Officer of the Company, effective on July 8, 2020. Ms. Chen indicated that her resignation was due to personal reasons.

Thus, the Company has been dormant since July 2020.

**Custodianship and Changes in Control of Registrant**

On April 12, 2022, the Eighth Judicial District Court in Clark County, Nevada Case No: A-22-849683-B appointed Custodian Ventures, managed by David Lazar, as the Company's custodian. On December 9, 2021, Mr. Lazar was appointed as the sole executive officer, Chief Executive Officer, and director.

On September 22, 2022, as a result of a private transaction 10,000,000 shares of Series A Preferred Stock, $0.001 par value per share (the "Preferred Shares") of the Company were transferred from Custodian Ventures LLC, a Wyoming limited liability company ("CV") to Yuan Xiaoyan. As a result, Ms. Yuan Xiaoyan became the holder of 90% of the voting rights of the issued and outstanding share capital of the Company. The consideration paid for the Shares was $430,000.

As a result of the transfer of the Preferred Shares from CV to Ms. Yuan Xiaoyan, on September 22, 2022, David Lazar resigned as the sole executive officer and director. Accordingly, Mr. Lazar ceased to be the Company's Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of the transfer of the Preferred Shares, Ms. Yuan Xiaoyan consented to act as the new Chief Executive Officer, President, Chief Financial Officer, and a Director of the Company.

On December 30, 2022, as a result of the completion of the reverse acquisition with Cambell International, Ms. Yuan Xiaoyan resigned from all of her roles at the Company, and Ms. Sun Xiuzhi was appointed as our Chief Executive Office, Chief Financial Officer, Chairman and Director of the board.

***Yuan Xiaoyan. Chief Executive Officer, President, Chief Financial Officer, President, Chief Financial Officer, Chairman and Director of the Board, from September 22, 2022 through December 30, 2022.***

 ****

Ms. Xiaoyan Yuan, age 34 graduated from Haibin College, Beijing Jiaotong University. From 2013 to 2016, she served as the administrative officer of United Business Association Beijing Representative Office, assisting in the preparation of various meetings and documents, and maintaining close contact with member units. From 2016 to 2020, she worked as the project manager of China Enterprise Finance (Beijing) Investment Fund Co., LTD., responsible for the implementation of the matters in the establishment and operation of the fund, the post-investment tracking of the invested projects, and the regular analysis of the fund and project ROI and valuation changes. From 2020 to 2022, she served as the assistant to the Chairman of the overseas listing group of small and medium-sized enterprises, mainly engaged in listing advisory services, and responsible for assisting enterprises to complete various preparations before listing.

***Ms. Sun Xiuzhi, Chief Executive Officer, Chief Financial Officer, Chairman and Director of the Board, starting from December 30, 2022***

Ms. Xiuzhi has served as the Company's Chief Executive Office, Chief Financial Officer and Director since the closing of the Reverse Acquisition on December 30, 2022. Since 2015 she has served as the Chairperson of Liaoning Kangbaier Biotechnology Development Co., Ltd, a company she founded which is focus on the research and development of technology related to natural β -carotene extraction as well as the commercialization of products derived from such technology. Ms. Xiuzhi attended Shenyang University of Technology where she received a degree in September 2015.

**CURRENT BUSINESS OPERATIONS**

As of the date of this Quarterly Report, the Company is a "shell company" under the federal securities laws. The Company has essentially no operating assets and its business strategy is primarily identifying new business and investment opportunities. Since the transfer of Preferred Shares to and appointment of Ms., Yuan Xiaoyan as sole executive officer and director, the Company has been exploring strategic alternatives to maximize shareholder value by seeking business acquisition opportunities, a merger with another company, or other similar actions. In furtherance of these efforts, we have been engaged in discussions and negotiations with LiaoNing KangBaiEr Biotechnology Development Co., Ltd. ("LKBD"), an entity organized in the Peoples Republic of China ("China"), whose primary business involves the manufacture and sale of a health supplement and related products based upon carotene in China.

In relation to pursuing such strategic alternatives and new business acquisition opportunities, including the one referred to in the previous sentence, the Company may suffer material adverse financial conditions in the event: (i) the Company is not able to consummate any transaction with LKBD or be able to find other suitable acquisition candidates; and (ii) the Company is unable to identify a profitable new line of business or deploy successfully our resources to operate profitably in such line of business.

The Company will face substantial competition in our efforts to identify and pursue a new business venture. The primary source of competition is expected to be from other companies organized and funded for similar purposes, including small venture capital firms, blank check companies, and wealthy investors, many of which may have substantially greater financial and other resources than we do. In light of our limited financial and human resources, the Company is at a competitive disadvantage compared to many of its competitors in its efforts to obtain an operating business or assets necessary to commence operations in a new field. Additionally, with the economic downturn caused by the coronavirus pandemic and inflationary pressures, many venture capital firms and similar firms and individuals have been seeking to acquire businesses at discounted rates. Therefore, the Company currently faces additional competition and resultant difficulty obtaining a business. The Company expects these conditions to persist at least until the economy recovers. Further, even if the Company is successful in obtaining a business or assets for new operations, the Company expects there to be enhanced barriers to entry in the marketplace in which it decides to operate as a result of reduced demand and/or increased raw material costs caused by the pandemic, inflationary pressures and other economic forces that are beyond our control.

**RESULTS OF OPERATIONS**

**Three Month Period Ended September 30, 2022** 

**Revenue.** We did not generate any revenue during the three month period ended September 30, 2022 or fiscal year ended June 30, 2022.

**Operating expenses:** During the three month period ended September 30, 2022, the Company incurred operating expenses in the amount of $9,350. Operating expenses primarily includes professional fees.

**Net loss.** Thus, this resulted in a net loss of $9,350 or ($0.00) per share for the three month period ended September 30, 2022. The weighted average number of shares outstanding was 6,250,750 for both the three month period ended September 30, 2022, respectively.

**LIQUIDITY AND CAPITAL RESOURCES**

**Three Month Period Ended September 30, 2022** 

As of September 30, 2022, total assets were $nil and our total liabilities were $nil due to lialblities assumed by the shareholder.

Stockholders' deficit increased from $56,230 as of September 30, 2022.

**Off-Balance Sheet Arrangements**

There were no off-balance sheet arrangements during the three month period ended September 30, 2022 that have, or are reasonably likely to have, a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests

**<u>ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>**

None

**<u>ITEM 4. CONTROLS AND PROCEDURES</u>**

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

**Changes in Internal Controls over Financial Reporting**

There was no change in the Company's internal control over financial reporting during the quarterly period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

We are not involved in any pending legal proceeding nor are we aware of any pending or threatened litigation against us.

**ITEM 1A. RISK FACTORS**

Not Applicable

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

None

**ITEM 3. DEFAULTS UPON SENIOR SECURITES**

None

**ITEM 4. MINE SAFETY DISCLOSURES.**

None

**ITEM 5. OTHER INFORMATION**

**Changes in Control of Registrant**

As stated above, on September 22, 2022, as a result of a private transaction 10,000,000 Preferred Shares of the Company were transferred from CV to Yuan Xiaoyan. As a result, Ms. Xiaoyan became the holder of 90% of the voting rights of the issued and outstanding share capital of the Company.

On September 22, 2022, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company's Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of the transfer, Yuan Xiaoyan consented to act as the new Chief Executive Officer, President, Chief Financial Officer, and a Director of the Company.

**ITEM 6. EXHIBITS**

The following exhibits are included as part of this report by reference:

---

| | |
|:---|:---|
| 31.1 | [Certification of Principal Executive and Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended\*](f10q0922ex31-1_bitmiscorp.htm) |
| 32.1 | [Certification of Principal Executive and Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*](f10q0922ex32-1_bitmiscorp.htm) |
| 101.INS | XBRL Instance Document\* |
| 101.SCH | XBRL Schema Document\* |
| 101.CAL | XBRL Calculation Linkbase Document\* |
| 101.DEF | XBRL Definition Linkbase Document\* |
| 101.LAB | XBRL Label Linkbase Document\* |
| 101.PRE | XBRL Presentation Linkbase Document\* |

---

\* filed herewith

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Beijing, CHINA on January 27, 2023.

---

| | |
|:---|:---|
| **BITMIS CORP.** | **BITMIS CORP.** |
| By: | */s/ Sun Xiuzhi* |
|  | *Sun Xiuzhi* |
|  | Chief Executive Officer |
|  | (Principal Executive Officer) |
|  | January 27, 2023 |
| By: | */s/ Sun Xiuzhi* |
|  | *Sun Xiuzhi* |
|  | Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |
|  | January 27, 2023 |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, SUN Xiuzhi, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of Bitmis Corp. (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this Quarterly Report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. disclosed in this report any change in the Company's internal control over financial reporting that occurred during the period covered by the Quarterly Report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the Company's auditors and the audit committee of the Company's Board of Directors (or persons performing the equivalent function):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal controls over financial reporting.

---

| | |
|:---|:---|
| Date: January 27, 2023 | */s/ Sun Xiuzhi* |
|  | Sun Xiuzhi<br> Chief Executive Officer<br> (Principal Executive Officer<br> and Principal Financial Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Bitmis Corp., a Nevada corporation (the "Corporation"), does hereby certify, to such officer's knowledge, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2022 (the "Form 10-Q") of the Corporation fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

---

| | |
|:---|:---|
| Date: January 27, 2023 | */s/ Sun Xiuzhi* |
|  | Sun Xiuzhi<br> Chief Executive Officer<br> (Principal Executive Officer<br> and Principal Financial Officer) |

---